BackEvaxion Biotech A/S Overview

Evaxion Biotech A/S Net Tangible Assets

Latest net tangible assets for EVAX: $13M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$13.21M
27.96% YoYΔ $2.89M vs prior year quarter

Peer average

Loading

Evaxion Biotech A/S Net Tangible Assets History

Loading

Evaxion Biotech A/S vs. peers: Net Tangible Assets Comparison

Loading

Evaxion Biotech A/S Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Evaxion Biotech A/S (EVAX) FAQ

As of the most recent data (March 2026), EVAX shows a net tangible assets of $13M. That compares with $10M in the prior-year period — up 28.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EVAX's net tangible assets is now $13M (was $10M) — a 28.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Evaxion Biotech A/S is outperforming or lagging.

Tracking EVAX's net tangible assets over time shows whether Evaxion Biotech A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $13M That compares with $10M in the prior-year period — up 28.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Evaxion Biotech A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $13M) with ownership activity and broader fundamentals.

Evaxion Biotech A/S's net tangible assets is $13M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.